Edition:
United Kingdom

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

4.29USD
19 Oct 2018
Change (% chg)

$0.03 (+0.70%)
Prev Close
$4.26
Open
$4.25
Day's High
$4.29
Day's Low
$4.21
Volume
1,825
Avg. Vol
14,596
52-wk High
$5.70
52-wk Low
$0.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jul 0.13 -0.176
FY 2018 Apr '18 0.84 -0.237
Jan '18 0.66 -0.165
Oct 1.65 -0.143
Jul 0.02 -0.232
FY 2017 Apr '17 0.04 -0.345
Jan '17 0.04 -0.330
Oct 0.06 -0.377
Jul 0.04 -0.337
FY 2016 Apr '16 0.06 -0.305
Jan '16 6.04 -0.235
Oct 0.05 -0.433
Jul 0.22 -0.398
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Apr-18 1 8.00 8.00 8.00 --
Year Ending Apr-19 1 53.00 53.00 53.00 186.00
Year Ending Apr-20 1 446.00 446.00 446.00 448.00
Earnings (per share)
Year Ending Apr-18 1 -0.69 -0.69 -0.69 --
Year Ending Apr-19 1 -0.50 -0.50 -0.50 -0.33
Year Ending Apr-20 1 0.46 0.46 0.46 0.40
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.91 33.65
P/E High - Last 5 Yrs. -- 40.50 45.13
P/E Low - Last 5 Yrs. -- 23.27 23.75
Beta 1.50 0.89 0.88
Price to Sales (TTM) 3,064.50 3.93 5.82
Price to Book (MRQ) 1.15 4.77 4.89
Price to Tangible Book (MRQ) -- 5.60 6.51
Price to Cash Flow (TTM) -- 22.55 22.93
% Owned Institutions -- 1.13 2.13

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.51
Dividend Yield - 5 Year Avg 0.00 1.58 1.52
Dividend 5 Year Growth Rate -- 4.41 5.40
Payout Ratio(TTM) -- 46.17 43.86

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -44.44 2.22 8.09
Sales (TTM) vs TTM 1 Yr. Ago -97.48 4.64 5.80
Sales - 5 Yr. Growth Rate -28.03 9.68 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.11 19.95 23.78
EPS (TTM) vs TTM 1 Yr. Ago 1.99 -- --
EPS - 5 Yr. Growth Rate -- 9.95 10.93
Capital Spending - 5 Yr. Growth Rate -36.33 15.08 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.63 2.18 2.25
Current Ratio (MRQ) 0.69 2.97 3.05
LT Debt to Equity (MRQ) 0.00 9.95 12.75
Total Debt to Equity (MRQ) 39.61 13.98 17.17
Interest Coverage (TTM) -11.13 41.52 37.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 1,837.18 55.19 54.87
Gross Margin - 5 Yr. Avg. 1,178.88 52.28 52.39
EBITD Margin (TTM) -84,689.74 -- --
EBITD - 5 Yr. Avg -6,042.16 18.46 11.02
Operating Margin (TTM) -87,538.46 14.31 4.30
Operating Margin - 5 Yr. Avg. -6,306.29 14.34 6.36
Pre-Tax Margin (TTM) -99,381.41 14.86 5.35
Pre-Tax Margin - 5 Yr. Avg. -6,879.22 14.79 6.80
Net Profit Margin (TTM) -99,381.41 11.08 1.62
Net Profit Margin - 5 Yr. Avg. -6,879.22 11.06 3.04
Effective Tax Rate (TTM) -- 23.36 23.24
Effective Tax Rate - 5 Yr. Avg. -- 23.59 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,364 909,900,986 808,425,748
Net Income/Employee (TTM) -2,349,015 107,071,320 95,083,073
Receivable Turnover (TTM) 0.06 5.62 5.77
Inventory Turnover (TTM) -0.18 2.61 3.63
Asset Turnover (TTM) 0.00 0.94 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -27.20 11.36 10.91
Return on Assets - 5 Yr. Avg. -25.00 12.60 12.01
Return on Investment (TTM) -44.58 14.75 14.28
Return on Investment - 5 Yr. Avg. -37.31 16.43 15.61
Return on Equity (TTM) -44.58 16.25 16.00
Return on Equity - 5 Yr. Avg. -37.54 17.49 16.87
  1 Year 3 Year 5 Year
Sales % -97.30 42.06 -28.03
EPS (TTM) % -1.95 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oasmia Pharmaceutical AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.57 -- 40 23
13 Week -14.78 -- 41 33
26 Week -58.33 -- 8 28
52 Week -66.42 -- 9 12
YTD -69.88 -- 6 24
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.33%
# of Holders: 10
Total Shares Held: 10,357,331
3 Mo. Net Change: 209,806
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.